Okyo Pharma revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, OKYO annual revenue was $0.0, with N/A growth year-over-year.
OKYO revenue history
Current Revenue
$0.0
Current Earnings
-$4.7M
Current Profit Margin
0%
Be the first to know when OKYO announces revenue.
OKYO Revenue History By Year
OKYO Yearly Revenue
OKYO Revenue
OKYO Change
OKYO Revenue Growth
2025-03-31
$0.00
N/A
N/A
2024-03-31
$0.00
N/A
N/A
2023-03-31
$0.00
N/A
N/A
2022-03-31
$0.00
N/A
N/A
2021-03-31
$0.00
N/A
N/A
2020-03-31
$0.00
N/A
N/A
1 of 1
Okyo Pharma Revenue FAQ
What was OKYO's revenue last quarter?
Okyo Pharma (NASDAQ: OKYO) reported Q1 2025 revenue of N/A up N/A year over year. In the same quarter last year, Okyo Pharma's revenue was N/A.
What was Okyo Pharma's revenue in 2025?
Okyo Pharma's annual revenue for the twelve months ending Mar 31, 2025 was $0.00, a N/A decrease year over year.
How much does Okyo Pharma make in a day?
Based on Okyo Pharma annual revenue for the past five years, OKYO makes an average of $0.00 per day.
What was Okyo Pharma's annual revenue growth in the past year?
As of Q3 2025, Okyo Pharma's revenue has grown null year over year. Okyo Pharma's revenue in the past year totaled $0.00.
How much does Okyo Pharma make in a year?
Okyo Pharma's revenue by year for the past five years is:
Okyo Pharma's revenue for the twelve months ending Mar 31, 2025 was $0.00, a N/A decrease year over year.
Okyo Pharma's annual revenue for Mar 31, 2024 was $0.00, a N/A decrease from 2023.
Okyo Pharma's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
Okyo Pharma's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Okyo Pharma's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.